FDA v. Alliance for Hippocratic Medicine - 23-719

The Court unanimously held that the plaintiffs lacked standing to challenge FDA actions expanding access to the abortion drug mifepristone. The doctors and organizations failed to show they suffered concrete injury from the FDA's decisions.